Skip to main content
Top
Published in: Journal of Cachexia, Sarcopenia and Muscle 3/2014

01-09-2014 | Original Article

Anabolic exercise in haemodialysis patients: a randomised controlled pilot study

Authors: Danielle L. Kirkman, Paul Mullins, Naushad A. Junglee, Mick Kumwenda, Mahdi M. Jibani, Jamie H. Macdonald

Published in: Journal of Cachexia, Sarcopenia and Muscle | Issue 3/2014

Login to get access

Abstract

Background

The anabolic response to progressive resistance exercise training (PRET) in haemodialysis patients is unclear. This pilot efficacy study aimed to determine whether high-intensity intradialytic PRET could reverse atrophy and consequently improve strength and physical function in haemodialysis patients. A second aim was to compare any anabolic response to that of healthy participants completing the same program.

Methods

In a single blind controlled study, 23 haemodialysis patients and 9 healthy individuals were randomly allocated to PRET or an attention control (SHAM) group. PRET completed high-intensity exercise leg extensions using novel equipment. SHAM completed low-intensity lower body stretching activities using ultra light resistance bands. Exercises were completed thrice weekly for 12 weeks, during dialysis in the haemodialysis patients. Outcomes included knee extensor muscle volume by magnetic resonance imaging, knee extensor strength by isometric dynamometer and lower body tests of physical function. Data were analysed by a per protocol method using between-group comparisons.

Results

PRET elicited a statistically and clinically significant anabolic response in haemodialysis patients (PRET—SHAM, mean difference [95 % CI]: 193[63 to 324] cm3) that was very similar to the response in healthy participants (PRET—SHAM, 169[−41 to 379] cm3). PRET increased strength in both haemodialysis patients and healthy participants. In contrast, PRET only enhanced lower body functional capacity in the healthy participants.

Conclusions

Intradialytic PRET elicited a normal anabolic and strength response in haemodialysis patients. The lack of a change in functional capacity was surprising and warrants further investigation.
Literature
1.
go back to reference Sakkas GK, Ball D, Mercer TH, Sargeant AJ, Tolfrey K, Naish PF. Atrophy of non-locomotor muscle in patients with end-stage renal failure. Nephrol Dial Transplant. 2003;18:2074–81. Sakkas GK, Ball D, Mercer TH, Sargeant AJ, Tolfrey K, Naish PF. Atrophy of non-locomotor muscle in patients with end-stage renal failure. Nephrol Dial Transplant. 2003;18:2074–81.
2.
go back to reference Johansen KL, Shubert T, Doyle J, Soher B, Sakkas GK, Kent-Braun JA. Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function. Kidney Int. 2003;63:291–7.PubMedCrossRef Johansen KL, Shubert T, Doyle J, Soher B, Sakkas GK, Kent-Braun JA. Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function. Kidney Int. 2003;63:291–7.PubMedCrossRef
3.
go back to reference Macdonald JH, Phanish MK, Marcora SM, Jibani M, Bloodworth LLO, Holly JMP, et al. Muscle insulin-like growth factor status, body composition, and functional capacity in hemodialysis patients. J Ren Nutr. 2004;14:248–52.PubMedCrossRef Macdonald JH, Phanish MK, Marcora SM, Jibani M, Bloodworth LLO, Holly JMP, et al. Muscle insulin-like growth factor status, body composition, and functional capacity in hemodialysis patients. J Ren Nutr. 2004;14:248–52.PubMedCrossRef
4.
go back to reference Workeneh BT, Mitch WE. Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr. 2010;91:1128S–32.PubMedCrossRef Workeneh BT, Mitch WE. Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr. 2010;91:1128S–32.PubMedCrossRef
5.
go back to reference Mak RH, Ikizler TA, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K. Wasting in chronic kidney disease (vol 2, pg 9, 2011). J Cachexia Sarcopenia Muscle. 2011;2:119.PubMedCrossRef Mak RH, Ikizler TA, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K. Wasting in chronic kidney disease (vol 2, pg 9, 2011). J Cachexia Sarcopenia Muscle. 2011;2:119.PubMedCrossRef
6.
go back to reference Huang CX, Tighiouart H, Beddhu S, Cheung AK, Dwyer JT, Eknoyan G, et al. Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int. 2010;77:624–9.PubMedCrossRefPubMedCentral Huang CX, Tighiouart H, Beddhu S, Cheung AK, Dwyer JT, Eknoyan G, et al. Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int. 2010;77:624–9.PubMedCrossRefPubMedCentral
7.
go back to reference Marrades RM, Roca J, Campistol JM, Diaz O, Barbera JA, Torregrosa JV, et al. Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure. J Clin Invest. 1996;97:2092–100.PubMedCrossRefPubMedCentral Marrades RM, Roca J, Campistol JM, Diaz O, Barbera JA, Torregrosa JV, et al. Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure. J Clin Invest. 1996;97:2092–100.PubMedCrossRefPubMedCentral
8.
go back to reference Cheema B, Abas H, Smith B, O’Sullivan AJ, Chan M, Patwardhan A, et al. Investigation of skeletal muscle quantity and quality in end-stage renal disease. Nephrology (Carlton). 2010;15:454–63.CrossRef Cheema B, Abas H, Smith B, O’Sullivan AJ, Chan M, Patwardhan A, et al. Investigation of skeletal muscle quantity and quality in end-stage renal disease. Nephrology (Carlton). 2010;15:454–63.CrossRef
9.
go back to reference Singh MAF, Ding WJ, Manfredi TJ, Solares GS, O’Neill EF, Clements KM, et al. Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders. Am Physiol Endocrinol Metab. 1999;277:E135–43. Singh MAF, Ding WJ, Manfredi TJ, Solares GS, O’Neill EF, Clements KM, et al. Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders. Am Physiol Endocrinol Metab. 1999;277:E135–43.
10.
go back to reference Lemmey AB, Marcora SM, Chester K, Wilson S, Casanova F, Maddison PJ. Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial. Arthritis Rheum. 2009;61:1726–34.PubMedCrossRef Lemmey AB, Marcora SM, Chester K, Wilson S, Casanova F, Maddison PJ. Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial. Arthritis Rheum. 2009;61:1726–34.PubMedCrossRef
11.
go back to reference Kopple JD, Wang H, Casaburi R, Fournier M, Lewis MI, Taylor W, et al. Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle. J Am Soc Nephrol. 2007;18:2975–86.PubMedCrossRef Kopple JD, Wang H, Casaburi R, Fournier M, Lewis MI, Taylor W, et al. Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle. J Am Soc Nephrol. 2007;18:2975–86.PubMedCrossRef
12.
go back to reference Balakrishnan VS, Rao M, Menon V, Gordon PL, Pilichowska M, Castaneda F, et al. Resistance training increases muscle mitochondrial biogenesis in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:996–1002.PubMedCrossRefPubMedCentral Balakrishnan VS, Rao M, Menon V, Gordon PL, Pilichowska M, Castaneda F, et al. Resistance training increases muscle mitochondrial biogenesis in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:996–1002.PubMedCrossRefPubMedCentral
13.
go back to reference Senior JR, Maroni BJ. Working group session report: chronic renal and gastrointestinal disease. J Nutr. 1999;129:313S–4.PubMed Senior JR, Maroni BJ. Working group session report: chronic renal and gastrointestinal disease. J Nutr. 1999;129:313S–4.PubMed
14.
go back to reference Chen JL, Godfrey S, Ng TT, Moorthi R, Liangos O, Ruthazer R, et al. Effect of intra-dialytic, low-intensity strength training on functional capacity in adult haemodialysis patients: a randomized pilot trial. Nephrol Dial Transplant. 2010;25:1936–43.PubMedCrossRefPubMedCentral Chen JL, Godfrey S, Ng TT, Moorthi R, Liangos O, Ruthazer R, et al. Effect of intra-dialytic, low-intensity strength training on functional capacity in adult haemodialysis patients: a randomized pilot trial. Nephrol Dial Transplant. 2010;25:1936–43.PubMedCrossRefPubMedCentral
15.
go back to reference Johansen KL, Painter PL, Sakkas GK, Gordon P, Doyle J, Shubert T. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial. J Am Soc Nephrol. 2006;17:2307–14.PubMedCrossRef Johansen KL, Painter PL, Sakkas GK, Gordon P, Doyle J, Shubert T. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial. J Am Soc Nephrol. 2006;17:2307–14.PubMedCrossRef
16.
go back to reference Cheema B, Abas H, Smith B, O’Sullivan A, Chan M, Patwardhan A, et al. Randomized controlled trial of intradialytic resistance training to target muscle wasting in ESRD: the progressive exercise for anabolism in kidney disease (PEAK) study. Am J Kidney Dis. 2007;50:574–84.PubMedCrossRef Cheema B, Abas H, Smith B, O’Sullivan A, Chan M, Patwardhan A, et al. Randomized controlled trial of intradialytic resistance training to target muscle wasting in ESRD: the progressive exercise for anabolism in kidney disease (PEAK) study. Am J Kidney Dis. 2007;50:574–84.PubMedCrossRef
17.
go back to reference Cheema B, Abas H, Smith B, O’Sullivan A, Chan M, Patwardhan A, et al. Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trial of resistance training during hemodialysis. J Am Soc Nephrol. 2007;18:1594–601.PubMedCrossRef Cheema B, Abas H, Smith B, O’Sullivan A, Chan M, Patwardhan A, et al. Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trial of resistance training during hemodialysis. J Am Soc Nephrol. 2007;18:1594–601.PubMedCrossRef
18.
go back to reference Spiering BA, Kraemer WJ, Anderson JM, Armstrong LE, Nindl BC, Volek JS, et al. Resistance exercise biology: manipulation of resistance exercise programme variables determines the responses of cellular and molecular signalling pathways. Sports Med. 2008;38:527–40.PubMedCrossRef Spiering BA, Kraemer WJ, Anderson JM, Armstrong LE, Nindl BC, Volek JS, et al. Resistance exercise biology: manipulation of resistance exercise programme variables determines the responses of cellular and molecular signalling pathways. Sports Med. 2008;38:527–40.PubMedCrossRef
19.
go back to reference Kraemer WJ, Adams K, Cafarelli E, Dudley GA, Dooly C, Feigenbaum MS, et al. Joint position statement: progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2002;34:364–80.PubMedCrossRef Kraemer WJ, Adams K, Cafarelli E, Dudley GA, Dooly C, Feigenbaum MS, et al. Joint position statement: progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2002;34:364–80.PubMedCrossRef
20.
go back to reference Albaaj F, Sivalingham M, Haynes P, McKinnon G, Foley RN, Waldek S, et al. Prevalence of hypogonadism in male patients with renal failure. Postgrad Med J. 2006;82:693–6.PubMedCrossRefPubMedCentral Albaaj F, Sivalingham M, Haynes P, McKinnon G, Foley RN, Waldek S, et al. Prevalence of hypogonadism in male patients with renal failure. Postgrad Med J. 2006;82:693–6.PubMedCrossRefPubMedCentral
21.
22.
go back to reference Mak RH, Cheung WW, Roberts Jr CT. The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res. 2008;18:17–25.PubMedCrossRefPubMedCentral Mak RH, Cheung WW, Roberts Jr CT. The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res. 2008;18:17–25.PubMedCrossRefPubMedCentral
23.
go back to reference Bryzycki M. Strength testing-predicting a one-rep max from a reps-to-fatigue. J Phys Edu Recreat Dance. 1993;64:88–90.CrossRef Bryzycki M. Strength testing-predicting a one-rep max from a reps-to-fatigue. J Phys Edu Recreat Dance. 1993;64:88–90.CrossRef
24.
go back to reference Painter PL, Krasnoff JB. End stage metabolic disease: renal failure and liver failure. In: Durstine JL, Moore GE, Painter PL, Roberts SO, editors. ACSM’s exercise management for persons with chronic diseases and disabilities. 3rd ed. Champaign, IL: Human Kinetics; 2009. p. 175–82. Painter PL, Krasnoff JB. End stage metabolic disease: renal failure and liver failure. In: Durstine JL, Moore GE, Painter PL, Roberts SO, editors. ACSM’s exercise management for persons with chronic diseases and disabilities. 3rd ed. Champaign, IL: Human Kinetics; 2009. p. 175–82.
25.
go back to reference Tracy BL, Ivey FM, Metter EJ, Fleg JL, Siegel EL, Hurley BF. A more efficient magnetic resonance imaging-based strategy for measuring quadriceps muscle volume. Med Sci Sports Exerc. 2003;35:425–33.PubMedCrossRef Tracy BL, Ivey FM, Metter EJ, Fleg JL, Siegel EL, Hurley BF. A more efficient magnetic resonance imaging-based strategy for measuring quadriceps muscle volume. Med Sci Sports Exerc. 2003;35:425–33.PubMedCrossRef
26.
go back to reference Macdonald JH, Marcora SM, Jibani MM, Kumwenda MJ, Ahmed W, Lemmey AB. Nandrolone decanoate as anabolic therapy in chronic kidney disease: a randomized phase II dose-finding study. Nephron Clin Pract. 2007;106:125–35.CrossRef Macdonald JH, Marcora SM, Jibani MM, Kumwenda MJ, Ahmed W, Lemmey AB. Nandrolone decanoate as anabolic therapy in chronic kidney disease: a randomized phase II dose-finding study. Nephron Clin Pract. 2007;106:125–35.CrossRef
27.
go back to reference Rikili R, Jones C. Senior fitness test manual. Champaign, IL: Human Kinetics; 2001. Rikili R, Jones C. Senior fitness test manual. Champaign, IL: Human Kinetics; 2001.
28.
go back to reference Ware JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User’s manual for the SF-36v2 health survey. QualityMetric: Lincoln, RI; 2007. Ware JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User’s manual for the SF-36v2 health survey. QualityMetric: Lincoln, RI; 2007.
29.
go back to reference Cohen J. Statistical power analysis for the behavioural sciences. Hillsdale: Lawrence Erlbaum Associates; 1988. Cohen J. Statistical power analysis for the behavioural sciences. Hillsdale: Lawrence Erlbaum Associates; 1988.
30.
go back to reference Headley S, Germain M, Mailloux P, Mulhern J, Ashworth B, Burris J, et al. Resistance training improves strength and functional measures in patients with end-stage renal disease. Am J Kidney Dis. 2002;40:355–64.PubMedCrossRef Headley S, Germain M, Mailloux P, Mulhern J, Ashworth B, Burris J, et al. Resistance training improves strength and functional measures in patients with end-stage renal disease. Am J Kidney Dis. 2002;40:355–64.PubMedCrossRef
31.
go back to reference Heiwe S, Jacobson SH. Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev. 2011;10:CD003236.PubMed Heiwe S, Jacobson SH. Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev. 2011;10:CD003236.PubMed
32.
go back to reference Hansen S, Kvorning T, Kjaer M, Sjogaard G. The effect of short-term strength training on human skeletal muscle: the importance of physiologically elevated hormone levels. Scand J Med Sci Sports. 2001;11:347–54.PubMedCrossRef Hansen S, Kvorning T, Kjaer M, Sjogaard G. The effect of short-term strength training on human skeletal muscle: the importance of physiologically elevated hormone levels. Scand J Med Sci Sports. 2001;11:347–54.PubMedCrossRef
33.
go back to reference Dong J, Ikizler TA. New insights into the role of anabolic interventions in dialysis patients with protein energy wasting. Curr Opin Nephrol Hypertens. 2009;18:469–75.PubMedCrossRefPubMedCentral Dong J, Ikizler TA. New insights into the role of anabolic interventions in dialysis patients with protein energy wasting. Curr Opin Nephrol Hypertens. 2009;18:469–75.PubMedCrossRefPubMedCentral
34.
35.
go back to reference Cheema BSB, Smith BCF, Singh MAF. A rationale for intradialytic exercise training as standard clinical practice in ESRD. Am J Kid Dis. 2005;45:912–6.PubMedCrossRef Cheema BSB, Smith BCF, Singh MAF. A rationale for intradialytic exercise training as standard clinical practice in ESRD. Am J Kid Dis. 2005;45:912–6.PubMedCrossRef
36.
go back to reference Macdonald JH, Marcora SM, Jibani M, Phanish MK, Holly J, Lemmey AB. Intradialytic exercise as anabolic therapy in haemodialysis patients—a pilot study. Clin Physiol Funct Imaging. 2005;25:113–8.PubMedCrossRef Macdonald JH, Marcora SM, Jibani M, Phanish MK, Holly J, Lemmey AB. Intradialytic exercise as anabolic therapy in haemodialysis patients—a pilot study. Clin Physiol Funct Imaging. 2005;25:113–8.PubMedCrossRef
37.
go back to reference Burholt V, Nash P. Short form 36 (SF-36) health survey questionnaire: normative data for wales. J Public Health (Oxf). 2011;33:587–603.CrossRef Burholt V, Nash P. Short form 36 (SF-36) health survey questionnaire: normative data for wales. J Public Health (Oxf). 2011;33:587–603.CrossRef
38.
go back to reference Hopkins M, Jeukendrup A, King NA, Blundell JE. The relationship between substrate metabolism, exercise and appetite control does glycogen availability influence the motivation to eat, energy intake or food choice? Sports Med. 2011;41:507–21.PubMedCrossRef Hopkins M, Jeukendrup A, King NA, Blundell JE. The relationship between substrate metabolism, exercise and appetite control does glycogen availability influence the motivation to eat, energy intake or food choice? Sports Med. 2011;41:507–21.PubMedCrossRef
39.
go back to reference Burd NA, Wall BT, van Loon LJC. The curious case of anabolic resistance: old wives’ tales or new fables? J Appl Physiol. 2012;112:1233–5.PubMedCrossRef Burd NA, Wall BT, van Loon LJC. The curious case of anabolic resistance: old wives’ tales or new fables? J Appl Physiol. 2012;112:1233–5.PubMedCrossRef
Metadata
Title
Anabolic exercise in haemodialysis patients: a randomised controlled pilot study
Authors
Danielle L. Kirkman
Paul Mullins
Naushad A. Junglee
Mick Kumwenda
Mahdi M. Jibani
Jamie H. Macdonald
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cachexia, Sarcopenia and Muscle / Issue 3/2014
Print ISSN: 2190-5991
Electronic ISSN: 2190-6009
DOI
https://doi.org/10.1007/s13539-014-0140-3

Other articles of this Issue 3/2014

Journal of Cachexia, Sarcopenia and Muscle 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine